The Third Session of Drug Development Boot Camp
For Biotech and Pharma Company Executives
November 20–21, 2013
Harvard Club, Boston, Massachusetts
With the trend of more complex and fierce drug development market, knowing the corresponding process and being able to navigate it with great skills will become more and more important. As Nobel Laureate scientists said, “Figuring out the drug development process is very bewildering”. Drug development, in some way involves developing new therapeutics, such as drugs, devices, combination products and diagnostics.
The two day courses for relevant biotech and pharma company executives will be jointly held by Harvard University Office of Technology Development and Speid & Associates, Inc. The online register is available now on its official website.
Dr. Speid is a global regulatory affairs and drug development expert. After watching many of her client companies make expensive and avoidable mistakes, she decided to help as many as possible avoid making the same mistakes over and over again. This two days course will be intensive and extensive. It helps making the proper decision on investment, on drug development direction, on mistakes avoiding, on market orientation and others.
Article Link:The Third Session of Drug Development Boot CampTags: Drug Development, Biotech and Pharma Executives, Learning Chance